Moreover, in the resistant luminal-excluded subtype, the investigators demonstrated that inhibition of KDM5B enhances immunogenicity in FGFR3-mutated urothelial carcinoma cells. This evidence concerns the gene FGFR3 and urothelial carcinoma.